GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » Valuation Rank

ToolGen (XKRX:199800) Valuation Rank


View and export this data going back to 2014. Start your Free Trial

What is ToolGen Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

ToolGen Valuation Rank Related Terms

Thank you for viewing the detailed overview of ToolGen's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

ToolGen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » Valuation Rank
Comparable Companies
XKRX:308430 XKRX:115180 XKRX:304360 XKRX:048870 XKRX:078160 XKRX:140610 XKRX:475960 XKRX:215600 XKRX:002630 XKRX:334970 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR
Website
http://www.toolgen.com
ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.